The use and challenges of immunotherapy in patients with MSI-H CRC is explored through 2 cases.
This activity is intended for oncologists, gastroenterologists, surgeons, nurses, pharmacists, and other healthcare professionals who treat patients with colorectal cancer (CRC).
The goal of this activity is to examine the management of microsatellite instability-high (MSI-H) CRC, including testing and treatment with immunotherapy.
Approximate Time to Complete: 30 minutes
Credit Available: Dec. 18, 2018 - Dec. 18, 2019
Developed through a partnership between SITC and Medscape.